Milwaukee-based biotech startup Geno.Me is focused on expanding its client base and boosting sales as it nears the close of its seed II funding round, which has a cap of more than $3 million.
Geno.Me links genomic and electronic health record data in an open marketplace, which allows medical researchers to more easily access data and patients to have more transparency and control of the use of their personal health and medical data, according to Britt Gottschalk, the company’s founder and chief executive officer. Patients who share their data are compensated.
Gottschalk has experience as a management consultant. She founded Geno.Me during the COVID-19 pandemic after she identified inefficiencies related to patient data transfer and accessibility in the American health care system.